Results 41 to 50 of about 4,527 (138)

Spotlight on Schlemm’s Canal MicroStent Injection in Patients with Glaucoma

open access: yesClinical Ophthalmology, 2023
Isabella V Wagner,1 Bryan Ang,2 Leticia Checo,1 Derya Simsek,3 Christian Draper,1 Syril Dorairaj1 1Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA; 2Department of Ophthalmology, Tan Tock Seng Hospital, Singapore; 3Department of ...
Wagner IV   +5 more
doaj  

Anterior Segment Optical Coherence Tomography Angiography Following Trabecular Bypass Minimally Invasive Glaucoma Surgery

open access: yesFrontiers in Medicine, 2022
ObjectiveTo assess anterior segment optical coherence tomography angiography (AS-OCTA) imaging of the episcleral vessels before and after trabecular bypass minimally invasive glaucoma surgery (MIGS).DesignA prospective, clinical, single-centre, single ...
Jinyuan Gan   +17 more
doaj   +1 more source

The Efficacy and Safety of High‐Frequency Deep Sclerotomy in Treatment of Chronic Open‐Angle Glaucoma Patients

open access: yesBioMed Research International, Volume 2019, Issue 1, 2019., 2019
Purpose. Highlights the high‐frequency deep sclerotomy as a competing ab interno surgery in open‐angle glaucoma patients and evaluates the efficacy of high‐frequency deep sclerotomy in lowering IOP of chronic open‐angle glaucoma patients, in addition to the evaluation of the safety of the procedure on the corneal endothelium. Design.
Mokhtar Mohamed Ibrahim Abushanab   +4 more
wiley   +1 more source

Development of a biodegradable microstent for minimally invasive treatment of Fallopian tube occlusions [PDF]

open access: yes, 2020
Obstructions of the Fallopian tube represent one of the most common reasons for an unfulfilled desire to have children. Microstent technology opens up new therapeutic possibilities to restore the natural lumen of the Fallopian tube within a single ...
Dierke Ariane   +39 more
core   +2 more sources

Hydrus<sup>®</sup> Microstent Combined with Cataract Surgery in Pseudoexfoliation Glaucoma Versus Primary Open Angle Glaucoma. [PDF]

open access: yesJ Clin Med
Background/Objectives: Our objective was to compare clinical outcomes of the Hydrus® Microstent implantation combined with cataract surgery in eyes with pseudoexfoliation glaucoma (PXG) and primary open angle glaucoma (POAG). Methods: This retrospective, single-center comparative cohort study included eyes with POAG or PXG undergoing combined cataract ...
Keidel LF   +6 more
europepmc   +2 more sources

A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma [PDF]

open access: yes, 2015
Purpose: To assess the safety and effectiveness of the Hydrus Microstent (Ivantis, Inc, Irvine, CA) with concurrent cataract surgery (CS) for reducing intraocular pressure (IOP) in open-angle glaucoma (OAG).
Lorenz, Katrin   +12 more
core   +1 more source

The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma

open access: yesOptometry and Vision Science, Volume 95, Issue 2, Page 155-162, February 2018., 2018
SIGNIFICANCE Noncompliance is a problem affecting glaucoma patients. Approaches to improve adherence include the use of drug‐delivery systems and safer forms of surgery. Minimally invasive glaucoma surgery (MIGS) has reduced complications, particularly in combination with cataract surgery, and with its good intraocular pressure (IOP) reduction may ...
Murray Fingeret, Jaime E. Dickerson Jr
wiley   +1 more source

Hydrus Microstent: Surgical modality for management of glaucoma

open access: yes, 2019
Purpose: To assess the effects of Hydrus microstent insertion on intraocular pressure and number of ocular hypotensive medications in patients with glaucoma or ocular hypertension.
Cronin, Brendan   +2 more
core   +1 more source

Safety and Efficacy of Microinvasive Glaucoma Surgery

open access: yesJournal of Ophthalmology, Volume 2017, Issue 1, 2017., 2017
Microinvasive glaucoma surgery (MIGS) is emerging as a new therapeutic option for glaucoma patients who wish to reduce their medication burden and avoid the postoperative complications of conventional glaucoma filtration surgery. These devices differ in terms of their efficacy and safety profile.
David Z. Chen   +2 more
wiley   +1 more source

Evaluation of Bleb Morphology and Reduction in IOP and Glaucoma Medication following Implantation of a Novel Gel Stent

open access: yesJournal of Ophthalmology, Volume 2017, Issue 1, 2017., 2017
Objective. To evaluate the efficacy and safety of the Xen Gel Stent and provide a macro‐ and microscopic analyses of bleb morphology. Methods. A prospective 12‐month study on patients with primary open‐angle glaucoma. Patients underwent implantation of the XEN Gel Stent (Allergan INC, Dublin, Ireland) either alone or combined with a cataract surgery ...
Antonio Maria Fea   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy